VKH
VBIV

Virtu KCG Holdings’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Virtu KCG Holdings’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$52K Sell
400
-2,707
-87% -$365K ﹤0.01% 2584
2017
Q1 		$512K Buy
+3,107
New +$421K 0.01% 1346
2015
Q1 		– Sell
-484
Closed -$48K – 4005
2014
Q4 		$48K Buy
+484
New +$38.2K ﹤0.01% 3447

Other funds holding VBIV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu KCG Holdings's VBIV Position: Q2 2017 in Review

Virtu KCG Holdings reduced its VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) stake by 87% in Q2 2017, selling an estimated $365K and leaving 400 shares worth $52K. The position accounts for ﹤0.01% of the portfolio, ranked #2584.

Virtu KCG Holdings first reported a position in VBIV in Q4 2014 and has held it in 3 quarters since. The position peaked at $512K in Q1 2017. 37 funds tracked by Wall St. Rank hold VBIV as of Q2 2017.

  • Virtu KCG Holdings held 400 shares of VBI Vaccines, Inc. New Common Stock (Canada) worth $52K as of Q2 2017.
  • Virtu KCG Holdings sold 2,707 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2017, an estimated $365K.
  • VBI Vaccines, Inc. New Common Stock (Canada) made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2584 holding.
  • Virtu KCG Holdings first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2014 and has held it in 3 quarters since.
  • Virtu KCG Holdings's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $512K in Q1 2017.
  • 37 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.